Related Experiment Videos
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
Lena Thyrell1, Sven Erickson, Boris Zhivotovsky
1Department of Oncology and Pathology, Cancer Center Karolinska (CCK), Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden.
Abstract:
Interferon alpha (IFNalpha) has been used in the treatment of several types of cancer for almost 30 years, yet the mechanism(s) responsible for its anti-tumoral action remains unknown. A variety of cellular responses, including inhibition of cell growth and induction of apoptosis are induced by IFNs, and apoptotic induction by this cytokine has been proposed to be of importance for both its anti-tumoral in addition to its anti-viral responses. The aim of the present study was to delineate the pathways activated during IFNalpha-induced apoptosis in malignant cell lines. We found that apoptosis induced by IFNalpha was associated with activation of caspases-1, -2, -3, -8 and -9 and that this activation was a critical event. Caspase-3 activation was dependent on activity of caspases-8 and -9, moreover, activation of caspase-8 seems to be the upstream event in IFNalpha-induced caspase cascade. We also found loss of mitochondrial membrane potential as well as release of cytochrome c post IFN-treatment, clearly implicating the involvement of mitochondria in IFN-mediated apoptosis. Furthermore, IFNalpha-induced apoptosis was found to be independent on interactions between the Fas-receptor and its ligand. These studies form the basis for further investigations aiming to improve IFN therapy and the development of future strategies to overcome the IFN resistance observed in some malignancies.
Insights
Interferon alpha (IFNalpha) triggers cancer cell death (apoptosis) by activating caspases and mitochondria. This research clarifies the specific pathways involved in IFNalpha
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Interferon alpha (IFNalpha) has been utilized in cancer therapy for decades.
- The precise mechanisms underlying its anti-tumoral effects, particularly apoptosis induction, remain incompletely understood.
- Understanding these pathways is crucial for optimizing IFNalpha treatments and overcoming resistance.
Purpose of the Study:
- To elucidate the molecular pathways activated by IFNalpha leading to apoptosis in malignant cell lines.
- To identify the key molecular players and signaling cascades involved in IFNalpha-induced cell death.
- To investigate the role of mitochondria and specific caspases in this process.
Main Methods:
- Treatment of malignant cell lines with IFNalpha.
- Analysis of caspase activation (caspases-1, -2, -3, -8, -9) using biochemical assays.
- Assessment of mitochondrial membrane potential and cytochrome c release.
- Evaluation of the role of the Fas-receptor/ligand pathway.
Main Results:
- IFNalpha treatment induced apoptosis associated with the activation of caspases-1, -2, -3, -8, and -9.
- Caspase-3 activation was dependent on caspase-8 and -9 activity, with caspase-8 acting as an upstream initiator.
- Mitochondrial involvement was confirmed through loss of membrane potential and cytochrome c release.
- IFNalpha-induced apoptosis proceeded independently of Fas-receptor/ligand interactions.
Conclusions:
- IFNalpha-induced apoptosis in cancer cells involves a caspase cascade initiated by caspase-8, leading to mitochondrial-mediated cell death.
- The findings highlight the critical role of caspases and mitochondria in IFNalpha's anti-tumoral mechanism.
- This study provides a foundation for improving IFNalpha-based cancer therapies and addressing treatment resistance.